
|Videos|April 22, 2020
A 67-Year-Old Man With NTRK Fusion-Positive Metastatic Lung Cancer
Author(s)Luis E. Raez, MD
Luis Raez, MD, reviews the case of a 67-year-old man with metastatic non-small cell NTRK gene fusion lung cancer.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
The Targeted Pulse: FDA Approvals, Trial Updates, and ASH 2025 Previews
2
HMA/Venetoclax Is Superior to Intensive Chemo in Fit Patients With AML
3
BRUIN Final Analysis: Pirtobrutinib Durable in Post-Covalent BTK CLL/SLL
4
Chemo-Free Ponatinib/Blinatumomab Improves Survival in Ph+ ALL
5






































